- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2013
- Public Summary Document (PSD) July 2013 PBAC Meeting - PDF
Alogliptin – July 2013
Alogliptin, tablets, 6,25 mg, 12,5 mg, 25 mg Nesina®
Last updated
8 November 2023